Literature DB >> 970286

Rapid purification of human high molecular weight kininogen.

F M Habal, H Z Movat.   

Abstract

Human high molecular weight kininogen was isolated by a rapid procedure, using anion exchange chromatography on QAE-Sephadex, ammonium sulfate precipitation and cation exchange chromatography on CM-Sephadex. The poor recovery and relatively low specific activity observed in earlier experiments was found to be due to a contaminant, presumably enzymatic, capable of releasing kinin from the kininogen. The "spontaneous" kinin release was blocked by soy bean trypsin inhibitor and by C1-inactivator. The isolated kininogen was stable at different temperatures, did not contain free kinin and was a good substrate for plasma kallikrein and plasmin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 970286     DOI: 10.1007/BF01971570

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  10 in total

1.  Further characterization of human plasma kininogens.

Authors:  F M Habal; B J Underdown; H Z Movat
Journal:  Biochem Pharmacol       Date:  1975-06-15       Impact factor: 5.858

2.  Some data on two purified kininogens from human plasma.

Authors:  S Jacobsen; M Kriz
Journal:  Br J Pharmacol Chemother       Date:  1967-01

3.  Purification and some properties of a kininogenase from human plasma activated by surface contact.

Authors:  U Wendel; W Vogt; G Seidel
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1972-10

4.  Two functionally different kininogens in human plasma.

Authors:  G Seidel
Journal:  Agents Actions       Date:  1973-05

5.  Isolation of two functionally different kininogens from human plasma--separation from proteinase inhibitors and interaction with plasma kallikrein.

Authors:  F M Habal; H Z Movat; C E Burrowes
Journal:  Biochem Pharmacol       Date:  1974-08-15       Impact factor: 5.858

6.  Kininogens of human plasma.

Authors:  F M Habal; H Z Movat
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-09

7.  Second kininase in human blood plasma.

Authors:  H Y Yang; E G Erdös
Journal:  Nature       Date:  1967-09-23       Impact factor: 49.962

8.  Flaujeac trait. Deficiency of human plasma kininogen.

Authors:  K D Wuepper; D R Miller; M J Lacombe
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

9.  Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.

Authors:  R W Colman; A Bagdasarian; R C Talamo; C F Scott; M Seavey; J A Guimaraes; J V Pierce; A P Kaplan
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

10.  Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.

Authors:  V H Donaldson; H I Glueck; M A Miller; H Z Movat; F Habal
Journal:  J Lab Clin Med       Date:  1976-02
  10 in total
  3 in total

1.  Surface activation of factor XII (Hageman factor)--critical role of high molecular weight kininogen and another potentiator).

Authors:  J Y Chan; C E Burrowes; H Z Movat
Journal:  Agents Actions       Date:  1978-01

2.  Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma.

Authors:  C F Scott; R W Colman
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

3.  High-molecular weight kininogen. A secreted platelet protein.

Authors:  A H Schmaier; A Zuckerberg; C Silverman; J Kuchibhotla; G P Tuszynski; R W Colman
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.